4-Chloro-7-Methoxyquinoline-6-Carboxamide CAS 417721-36-9 Mama>98.5% (HPLC) Lenvatinib Mesylate Intermediate Factory

Fa'amatalaga Puupuu:

Igoa: 4-Chloro-7-Methoxyquinoline-6-Carboxamide

CAS: 417721-36-9

Mama: >98.5% (HPLC)

Fa'aaliga: Pa'epa'e-Pa'epa'e i le Pa'u Samasama Malamalama

Intermediate o Lenvatinib Mesylate CAS 857890-39-2

Tulaga Maualuga, Gaosiga Fa'apisinisi

E-Mail: alvin@ruifuchem.com


Fa'amatalaga Oloa

Oloa Fa'atatau

Faailoga o oloa

Fa'amatalaga:

Meatotino tau vailaau:

Igoa Vailaau 4-Chloro-7-Methoxyquinoline-6-Carboxamide
Synonyms 4-Chloro-7-Methoxy-6-Quinolinecarboxamide;Lenvatinib Le mama 12;Lenvatinib Le mama B;Lenvatinib Le mama LFS-B
Numera CAS 417721-36-9
CAT Numera RF-PI1971
Tulaga Fa'asoa I Fa'atauga, Gaosi Gaosi 50MT/Tausaga
Fuafua mole C11H9ClN2O2
Molecular Weight 236.65
Lisi Lisi >205℃ (tes.)
Malosi 1.380±0.060g/cm3
Fa'ailoga Ruifu Chemical

Fa'amatalaga:

Aitema Fa'amatalaga
Fa'aaliga Pa'epa'e-Pa'epa'e i le Pa'u Samasama Malamalama
Mama / Suʻesuʻega Metotia >98.5% (HPLC)
Ma'imau ile Fa'amago <0.50%
Toega i luga o le mumu <0.50%
Aofa'i Fa'aleaga <1.50%
Proton NMR Alaleo E tusa ai ma le Fauga
Tulaga Su'ega Pisinisi Tulaga
Fa'aoga Intermediate o Lenvatinib Mesylate (CAS: 857890-39-2)

Paket & Teuina:

afifi: Fagu, ato pepa alumini, 25kg/Kati Pusa, pe tusa ai ma manaoga o tagata faatau

Tulaga teuina:Teu i totonu o pusa faʻamaufaʻailoga i se nofoaga malulu ma mago;Puipui mai le malamalama ma le susu

Tulaga lelei:

1

FAQ:

Talosaga:

4-Chloro-7-Methoxyquinoline-6-Carboxamide (CAS: 417721-36-9) e masani ona faʻaaogaina e avea o se vaeluaga ole Lenvatinib Mesylate (CAS: 857890-39-2).Na atiaʻe e Eisai Inc., lenvatinib mesylate o se vascular endothelial growth factor receptor (VEGF) inhibitor o loʻo i ai le gaioiga e faasaga i le VEGF subtypes 1, 2, ma le 3 ma na faʻatagaina e le FDA i le 2015 mo le togafitiga o le kanesa thyroid eseese lea e faʻapitonuʻu. faifai pea, metastatic, poʻo le alualu i luma ma e leʻi tali atu i togafitiga iodine radioactive.I le masina o Me 2016, na faʻamaonia ai e le FDA le vailaʻau e avea o se togafitiga faʻatasi ma everolimus mo le togafitiga o le gasegase o le tino.Talu ai ona o le VEGF (ma le fibroblast growth factor receptors, ua taʻua o FGFRs) e manatu e faia se sao i ala cardiovascular signaling, o le VEGF2R ma le FGFR inhibition o loʻo manatu o auala ia i tua atu o aʻafiaga muamua o le lenvatinib mesylate, o le toto maualuga.

Tusi lau savali iinei ma lafo mai ia i matou